tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AIM Stock Latest News

AIM ImmunoTech price target lowered to $1 from $2 at Maxim
The FlyAIM ImmunoTech price target lowered to $1 from $2 at Maxim
18d ago
AIM
AIM ImmunoTech granted U.S. patent for Ampligen for endometriosis treatment
PremiumThe Fly
AIM ImmunoTech granted U.S. patent for Ampligen for endometriosis treatment
1M ago
AIM
AIM ImmunoTech prices 4.65M shares at 27c in registered direct offering
PremiumThe Fly
AIM ImmunoTech prices 4.65M shares at 27c in registered direct offering
1M ago
AIM
AIM reports preliminary data in Phase 1b/2 study of Ampligen, Imfinzi
PremiumThe Fly
AIM reports preliminary data in Phase 1b/2 study of Ampligen, Imfinzi
2M ago
AIM
AZN
AIM ImmunoTech Adjusts Executive Compensation and Agreements
PremiumCompany Announcements
AIM ImmunoTech Adjusts Executive Compensation and Agreements
2M ago
8K
AIM
AIM ImmunoTech completed a clinical patient data analysis on AMP-518
PremiumThe FlyAIM ImmunoTech completed a clinical patient data analysis on AMP-518
2M ago
AIM
AIM ImmunoTech announces official print of data analysis for EAP study of PDAC
Premium
The Fly
AIM ImmunoTech announces official print of data analysis for EAP study of PDAC
3M ago
AIM
Morning Movers: MSG Entertainment rises following quarterly release
Premium
The Fly
Morning Movers: MSG Entertainment rises following quarterly release
3M ago
AIM
HRB
AIM ImmunoTech reports Q2 EPS (3c), consensus (12c)
PremiumThe Fly
AIM ImmunoTech reports Q2 EPS (3c), consensus (12c)
3M ago
AIM
AIM ImmunoTech announces data on Ampligen’s anti-tumor potential
PremiumThe Fly
AIM ImmunoTech announces data on Ampligen’s anti-tumor potential
4M ago
AIM
AIM ImmunoTech files to sell 11.28M shares of common stock for holders
PremiumThe Fly
AIM ImmunoTech files to sell 11.28M shares of common stock for holders
4M ago
AIM
AIM ImmunoTech to sell 5.6M shares at 36.3c in registered direct offering
PremiumThe Fly
AIM ImmunoTech to sell 5.6M shares at 36.3c in registered direct offering
5M ago
AIM
AIM ImmunoTech reports Q1 EPS (12c) vs (8c) last year
PremiumThe FlyAIM ImmunoTech reports Q1 EPS (12c) vs (8c) last year
6M ago
AIM
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
AIM
CVM
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
AIM
BCRX
AIM ImmunoTech completes cGMP manufacturing of clinical vials of Ampligen
PremiumThe Fly
AIM ImmunoTech completes cGMP manufacturing of clinical vials of Ampligen
6M ago
AIM
AIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
PremiumThe Fly
AIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
6M ago
AIM
AZN
AIM ImmunoTech files to sell 9.98M shares of common stock for holders
PremiumThe Fly
AIM ImmunoTech files to sell 9.98M shares of common stock for holders
7M ago
AIM
AIM ImmunoTech announces reslease of CEO Corner segment
PremiumThe Fly
AIM ImmunoTech announces reslease of CEO Corner segment
7M ago
AIM
AIM ImmunoTech appoints Lapp as a consulting Medical Officer
PremiumThe FlyAIM ImmunoTech appoints Lapp as a consulting Medical Officer
7M ago
AIM
AIM ImmunoTech announces interim report data from Ampligen study
Premium
The Fly
AIM ImmunoTech announces interim report data from Ampligen study
7M ago
AIM
Navigating the Future: Aim Immunotech’s Challenge Against Rapid Tech Evolution in Pharma
Premium
Company Announcements
Navigating the Future: Aim Immunotech’s Challenge Against Rapid Tech Evolution in Pharma
7M ago
AIM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >